The latest coronavirus developments and scientific research on prevention and treatment.
Researchers from Virginia Commonwealth University and Case Western Reserve University conducted weekly and monthly surveys of primary care clinicians to examine the use of telemedicine during the COVID-19… read more.
Ivermectin is an effective antiviral agent with a long record of successful use in human and animal parasite infestations. Its value as part of the early treatment for… read more.
Long Covid, which affects nearly two-million people in the UK1, is not caused by an immune inflammatory reaction to COVID-19, University of Bristol-led research finds. Emerging data demonstrates that… read more.
During the pandemic, contact tracing apps kept Americans informed of potential exposure risk with the goal of reducing infections. But did apps like this help reduce the spread… read more.
New research led by the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) at King’s College London has found that community mental health patients who were prescribed antidepressants were… read more.
A small, randomised trial in patients with post-COVID syndrome has found that hyperbaric oxygen therapy (HBOT) promotes restoration of the heart’s ability to contract properly. The research was… read more.
The European Medicines Agency (EMA) was praised for its contribution to the EU’s pandemic response, as the agency took steps to review the role of its Emergency Task… read more.
Vaccines against COVID-19, administered in the EU in the autumn of 2023, will be updated to target XBB forms of the SARS-CoV-2 virus. These strains are a subgroup… read more.
The COVID-19 pandemic took a toll on the mental health of health-care workers across the world. Most reported increased levels of stress and anxiety early in the pandemic… read more.
During the COVID-19 pandemic, many patients experienced a loss of taste and smell during and after being infected with SARS-CoV-2. A retrospective study by researchers at Massachusetts Eye and… read more.
Treatment with the diabetes drug metformin immediately after testing positive for the SARS-CoV-2 virus lowers the risk of developing long COVID by 41%. Researchers reported this finding on… read more.
Researchers interviewed primary care clinicians to identify trends, facilitators and barriers in implementing and using telemedicine technologies in response to the COVID-19 pandemic. They interviewed 25 leaders from… read more.
Advertisment
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
